BMI1 and neuroblastoma: Increased expression of BMI-1 has been implicated in cancers, including colorectal, non-small cell pulmonary, hepatocellular, prostate, and breast cancer, medulloblastoma, multiple myeloma, and neuroblastoma [33-36].